| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 343 |
| 1 | PREDNISONE | 243 |
| 2 | METHOTREXATE SODIUM | 240 |
| 3 | ACETAMINOPHEN | 233 |
| 4 | METHOTREXATE | 220 |
| 5 | ALENDRONATE SODIUM | 209 |
| 6 | DICLOFENAC SODIUM | 207 |
| 7 | RITUXIMAB | 205 |
| 8 | TOCILIZUMAB | 204 |
| 9 | ERGOCALCIFEROL | 198 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HYDROCHLORIDE | 9 | 0.0462 |
| 1 | CALCIUM CHLORIDE INJECTION | 83 | 0.0267 |
| 2 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 12 | 0.0182 |
| 3 | GOLIMUMAB | 159 | 0.0126 |
| 4 | CAFFEINE CITRATE | 29 | 0.0124 |
| 5 | PSEUDOEPHEDRINE HCL | 133 | 0.0121 |
| 6 | TOFACITINIB CITRATE | 154 | 0.0115 |
| 7 | CORTISONE ACETATE | 139 | 0.0111 |
| 8 | ALMOTRIPTAN | 11 | 0.0104 |
| 9 | NAPROXEN SODIUM 220MG | 128 | 0.0093 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 444 |
| 1 | Corticosteroid [EPC] | 412 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 303 |
| 3 | Vitamin C [EPC] | 267 |
| 4 | Proton Pump Inhibitor [EPC] | 234 |
| 5 | Benzodiazepine [EPC] | 228 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 222 |
| 7 | Vitamin B12 [EPC] | 218 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 216 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 208 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Disclosing Agent [EPC] | 1 | 0.0476 |
| 1 | Interleukin-5 Antagonist [EPC] | 26 | 0.0378 |
| 2 | Polyene Antimicrobial [EPC] | 4 | 0.0098 |
| 3 | Endoglycosidase [EPC] | 13 | 0.0070 |
| 4 | Provitamin D2 Compound [EPC] | 198 | 0.0067 |
| 5 | Interleukin-17A Antagonist [EPC] | 181 | 0.0049 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 32 | 0.0037 |
| 7 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 38 | 0.0023 |
| 8 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 9 | Aminosalicylate [EPC] | 195 | 0.0019 |